E
Element Science
Lifesaving wearable solutions designed to deliver an outstanding experience
About Element Science
Element Science is a health technology startup focused on combating the threat of sudden cardiac arrest. The company's primary product is Jewel®, a wearable defibrillator designed to provide 24/7 protection. This device is not yet commercially available in the U.S., but it represents a significant innovation in the medical technology market.
The company operates in the healthcare sector, specifically in the medical device sub-sector. Its target clients are individuals at risk of sudden cardiac arrest, a group that includes millions of people worldwide. The business model of Element Science is centered around the sale of its wearable defibrillator. Once commercially available, the company will generate revenue from the sale of these devices to individuals, healthcare providers, or insurance companies.
Element Science is also committed to making a positive impact on people's lives beyond its product offering. The company emphasizes diversity, equity, inclusion, and belonging (DEIB) in its workforce, reflecting its belief that everyone deserves to thrive in life and in the workplace.
In addition to its product and DEIB initiatives, Element Science is actively seeking to expand its team, indicating potential growth and expansion in the future. This could lead to increased market share and revenue, making it a company to watch in the medical technology sector.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- San Francisco, United States
- Employees
- 84
- Open positions
- 6
- Dealroom signal
- 54.2/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Cardiology and cardiovascular, Spinout, Wearable, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Mar 2020 | $146M | $582M | Third Rock Ventures · Cormorant Asset Management · Qiming Venture Partners USA · Invus | ↗ |
| SERIES BOther financing | Aug 2016 | $25M | $100M | Third Rock Ventures | — |
Growth signals
Latest recorded traffic for Element Science is 3.2K monthly website visits, up 33.3% over the last three months. Element Science's team grew 3.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Third Rock Ventures- PPProspect Venture Partners
Series B and later5 investors entered at this stage
Qiming Venture Partners USA
Deerfield
Cormorant Asset Management
Invus
Qiming Venture Partners
Other known investors1 additional known investor
Stanford University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Element Science on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Element Science’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.